Phase III Study Treatment of CLL B and C

Clinical trial NCT00535912 · COMPLETED

Trial details

NCT number: NCT00535912
Sponsor: French Innovative Leukemia Organisation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic

Start date: 1999-01-01
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.